A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease

NCT03151382 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Cognitive Function

Interventions

DRUG: Tandospirone Citrate
DRUG: Donepezil Hydrochloride

Sponsor

Zhejiang Provincial People's Hospital